151 related articles for article (PubMed ID: 8896888)
1. Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit Case-Control Study.
Potter JD; Bostick RM; Grandits GA; Fosdick L; Elmer P; Wood J; Grambsch P; Louis TA
Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):779-84. PubMed ID: 8896888
[TBL] [Abstract][Full Text] [Related]
2. Do factors related to endogenous and exogenous estrogens modify the relationship between obesity and risk of colorectal adenomas in women?
Wolf LA; Terry PD; Potter JD; Bostick RM
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):676-83. PubMed ID: 17416757
[TBL] [Abstract][Full Text] [Related]
3. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms.
Potter JD; Bigler J; Fosdick L; Bostick RM; Kampman E; Chen C; Louis TA; Grambsch P
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):69-75. PubMed ID: 9950242
[TBL] [Abstract][Full Text] [Related]
4. Recent use of hormone replacement therapy and the prevalence of colorectal adenomas.
Chen MJ; Longnecker MP; Morgenstern H; Lee ER; Frankl HD; Haile RW
Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):227-30. PubMed ID: 9521438
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy and risk of colon and rectal cancer.
Fernandez E; La Vecchia C; Braga C; Talamini R; Negri E; Parazzini F; Franceschi S
Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):329-33. PubMed ID: 9568789
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in PTGS1 (=COX-1) and risk of colorectal polyps.
Ulrich CM; Bigler J; Sparks R; Whitton J; Sibert JG; Goode EL; Yasui Y; Potter JD
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):889-93. PubMed ID: 15159324
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential?
Morimoto LM; Newcomb PA; Ulrich CM; Bostick RM; Lais CJ; Potter JD
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1012-8. PubMed ID: 12376501
[TBL] [Abstract][Full Text] [Related]
9. Oral contraceptive use and risk of colorectal cancer.
Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
Windler E; Zyriax BC; Eidenmüller B; Boeing H
Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
[TBL] [Abstract][Full Text] [Related]
11. Does a family history of cancer increase the risk for postmenopausal endometrial carcinoma? A prospective cohort study and a nested case-control family study of older women.
Olson JE; Sellers TA; Anderson KE; Folsom AR
Cancer; 1999 Jun; 85(11):2444-9. PubMed ID: 10357416
[TBL] [Abstract][Full Text] [Related]
12. Lack of association between the C677T MTHFR polymorphism and colorectal hyperplastic polyps.
Ulrich CM; Kampman E; Bigler J; Schwartz SM; Chen C; Bostick R; Fosdick L; Beresford SA; Yasui Y; Potter JD
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):427-33. PubMed ID: 10794488
[TBL] [Abstract][Full Text] [Related]
13. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer.
Slattery ML; Potter JD; Curtin K; Edwards S; Ma KN; Anderson K; Schaffer D; Samowitz WS
Cancer Res; 2001 Jan; 61(1):126-30. PubMed ID: 11196149
[TBL] [Abstract][Full Text] [Related]
14. Lack of evidence for effect modification by estrogen of association between body mass index and colorectal cancer risk among postmenopausal women.
Wang Y; Jacobs EJ; Teras LR; Pavluck AL; Rodriguez C; Thun MJ; Calle EE
Cancer Causes Control; 2007 Oct; 18(8):793-9. PubMed ID: 17619155
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy as a risk factor for non-small cell lung cancer: results of a case-control study.
Ramnath N; Menezes RJ; Loewen G; Dua P; Eid F; Alkhaddo J; Paganelli G; Natarajan N; Reid ME
Oncology; 2007; 73(5-6):305-10. PubMed ID: 18493157
[TBL] [Abstract][Full Text] [Related]
16. No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy.
Hoffmeister M; Raum E; Krtschil A; Chang-Claude J; Brenner H
Clin Pharmacol Ther; 2009 Oct; 86(4):416-24. PubMed ID: 19606090
[TBL] [Abstract][Full Text] [Related]
17. Frequency of colorectal polyps in patients with sporadic adenomas or adenocarcinomas of the papilla of vater--an age-matched, controlled study.
Schneider AR; Seifert H; Trojan J; Stein J; Hoepffner NM
Z Gastroenterol; 2005 Oct; 43(10):1123-7. PubMed ID: 16220451
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for advanced colorectal adenomas: a pooled analysis.
Terry MB; Neugut AI; Bostick RM; Sandler RS; Haile RW; Jacobson JS; Fenoglio-Preiser CM; Potter JD
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):622-9. PubMed ID: 12101109
[TBL] [Abstract][Full Text] [Related]
19. Increased incidence of colorectal adenomas in follow-up evaluation of patients with newly diagnosed hyperplastic polyps.
Huang EH; Whelan RL; Gleason NR; Maeda JS; Terry MB; Lee SW; Neugut AI; Forde KA
Surg Endosc; 2001 Jul; 15(7):646-8. PubMed ID: 11591960
[TBL] [Abstract][Full Text] [Related]
20. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
